Pulse Biosciences
(NASDAQ) PLSE
Pulse Biosciences Financials at a Glance
Market Cap
$1.40B
Revenue (TTM)
$350.00K
Net Income (TTM)
$72.78M
EPS (TTM)
$-1.08
P/E Ratio
-19.05
Dividend
$0.00
Beta (Volatility)
1.36 (Average)
Dividend
$0.00
Beta (Volatility)
1.36 (Average)
Price
$19.67
Volume
8,018
Open
$21.13
Price
$19.67
Volume
8,018
Open
$21.13
Previous Close
$19.67
Daily Range
$19.40 - $21.13
52-Week Range
$12.56 - $26.30
Dividend
$0.00
Beta (Volatility)
1.36 (Average)
Price
$19.67
Volume
8,018
Open
$21.13
Previous Close
$19.67
Daily Range
$19.40 - $21.13
52-Week Range
$12.56 - $26.30
PLSE News
PLSE: Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Pulse Biosciences
Industry
Healthcare Equipment and Supplies
Sector
Health CareEmployees
116
CEO
Paul A. LaViolette, MBA
Website
www.pulsebiosciences.comHeadquarters
Miami, CA 94545, US
PLSE Financials
Key Financial Metrics (TTM)
Gross Margin
-2%
Operating Margin
-220%
Net Income Margin
-208%
Return on Equity
-74%
Return on Capital
-87%
Return on Assets
-76%
Earnings Yield
-5.25%
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
$1.40B
Shares Outstanding
67.99M
Volume
8.02K
Short Interest
0.00%
Avg. Volume
330.92K
Financials (TTM)
Gross Profit
$1.26M
Operating Income
$76.94M
EBITDA
$71.71M
Operating Cash Flow
$54.12M
Capital Expenditure
$315.00K
Free Cash Flow
$54.44M
Cash & ST Invst.
$80.73M
Total Debt
$7.53M
Pulse Biosciences Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonEarnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$264.00K
N/A
Gross Profit
$255.00K
N/A
Gross Margin
-96.59%
N/A
Market Cap
$1.40B
N/A
Market Cap/Employee
$18.65M
N/A
Employees
75
N/A
Net Income
$17.43M
+10.1%
EBITDA
$17.17M
+14.0%
Quarterly Fundamentals
Net Cash
$73.20M
-32.9%
Accounts Receivable
$274.00K
N/A
Inventory
$136.00K
N/A
Long Term Debt
$5.96M
-21.0%
Short Term Debt
$1.57M
+15.9%
Return on Assets
-75.72%
N/A
Return on Invested Capital
-87.24%
N/A
Free Cash Flow
$14.86M
-61.6%
Operating Cash Flow
$14.76M
-61.4%